 |
| |
| Apr-07-17 | Reiterated |
Cantor Fitzgerald |
Overweight |
$20 → $21 |
|
| Mar-30-17 | Downgrade |
KeyBanc Capital Mkts |
Overweight → Sector Weight |
|
|
| Feb-08-17 | Initiated |
Barclays |
Equal Weight |
$17 |
|
| Nov-04-16 | Initiated |
Cantor Fitzgerald |
Buy |
|
|
| Apr-08-16 | Resumed |
Piper Jaffray |
Neutral |
|
|
| Jan-08-16 | Reiterated |
Canaccord Genuity |
Buy |
$17.50 → $14.50 |
|
| Nov-10-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Jul-24-15 | Initiated |
KeyBanc Capital Mkts |
Overweight |
|
|
| Jun-19-14 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$16.25 → $20 |
|
| Oct-09-12 | Reiterated |
Canaccord Genuity |
Hold |
$14 → $13.50 |
|
| Jun-25-12 | Downgrade |
Canaccord Genuity |
Buy → Hold |
$16.50 → $14.50 |
|
| Jul-15-11 | Upgrade |
Stifel Nicolaus |
Hold → Buy |
$16.50 |
|
| Jul-15-11 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$15 → $16.50 |
|
| Jun-14-11 | Downgrade |
Wedbush |
Neutral → Underperform |
$14 → $12 |
|
| Sep-08-10 | Reiterated |
Wedbush |
Neutral |
$17.50 → $14 |
|
| Mar-04-10 | Initiated |
Wedbush Morgan |
Neutral |
$17.50 |
|
| Sep-04-09 | Reiterated |
Caris & Company |
Above Average |
$13 → $15 |
|
| Jul-17-09 | Reiterated |
Caris & Company |
Above Average |
$15 → $13 |
|
| Jan-07-09 | Downgrade |
Caris & Company |
Buy → Above Average |
$20 → $15 |
|
| Nov-13-08 | Initiated |
Stifel Nicolaus |
Hold |
|
|
|
|
| Sep-18-17 08:06AM | AngioDynamics' BioFlo Platform Strong, Debt Levels High Zacks |
| Sep-14-17 07:00AM | Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open GlobeNewswire |
| 06:00AM | AngioDynamics to Report Fiscal 2018 First Quarter Financial Results GlobeNewswire |
| Sep-13-17 06:00AM | AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire |
| Aug-29-17 06:00AM | AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference GlobeNewswire |
| Aug-18-17 04:20PM | ETFs with exposure to AngioDynamics, Inc. : August 18, 2017 Capital Cube |
| 03:41AM | AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? Zacks |
| Aug-12-17 11:40PM | Edited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT Thomson Reuters StreetEvents |
| Aug-08-17 09:52AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 Capital Cube |
| Aug-07-17 07:49AM | AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference GlobeNewswire |
| Jul-27-17 04:25PM | IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| Jul-26-17 09:19AM | INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO PR Newswire |
| Jul-24-17 06:56PM | INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire +7.35% |
| 01:21PM | Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc. PR Newswire |
| Jul-21-17 05:00PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO Accesswire |
| Jul-19-17 09:08AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 Capital Cube |
| 09:08AM | AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Zacks |
| Jul-18-17 06:23PM | IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.78% |
| 06:21PM | ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations Business Wire |
| 05:43PM | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc. Business Wire |
| 04:49PM | AngioDynamics reports 4Q loss Associated Press |
| 03:28PM | IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| 02:32PM | ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm PR Newswire |
| 02:11PM | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) PR Newswire |
| 01:05PM | SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| 12:00PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO PR Newswire |
| 06:00AM | AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results GlobeNewswire |
| Jul-07-17 06:00AM | AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results GlobeNewswire |
| Jun-15-17 04:06PM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : June 15, 2017 Capital Cube |
| 01:03PM | ETFs with exposure to AngioDynamics, Inc. : June 15, 2017 Capital Cube |
| Jun-14-17 08:20AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017 Capital Cube |
| Jun-09-17 08:15AM | Featured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System Accesswire |
| Jun-07-17 06:00AM | AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System GlobeNewswire |
| May-31-17 03:48PM | Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals |
| 06:00AM | AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access GlobeNewswire |
| May-09-17 06:00AM | AngioDynamics to Present at the 2017 UBS Global Healthcare Conference GlobeNewswire |
| May-01-17 03:11AM | AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound? Zacks |
| Apr-20-17 06:00AM | AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference GlobeNewswire |
| Apr-10-17 10:06AM | AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering Zacks |
| 08:32AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 10, 2017 Capital Cube |
| Apr-07-17 09:25AM | Endo international, AngioDynamics Lead Biotech Movers TheStreet.com |
| Apr-06-17 07:49PM | AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire |
| 04:02PM | AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders GlobeNewswire |
| Apr-05-17 04:18PM | ETFs with exposure to AngioDynamics, Inc. : April 5, 2017 Capital Cube |
| Apr-04-17 05:54PM | 5 Cheap Value Stocks to Tame a Capricious Market in Q2 Zacks |
| 09:23AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2017 By the Numbers : April 4, 2017 Capital Cube |
| Apr-03-17 10:57AM | ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report |
| Mar-31-17 11:04AM | AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks |
| Mar-30-17 07:32PM | Edited Transcript of ANGO earnings conference call or presentation 30-Mar-17 12:00pm GMT Thomson Reuters StreetEvents |
| 01:35PM | AngioDynamics downgraded by KeyBanc Capital Mkts |
| 08:02AM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit |
| 07:07AM | Q3 2017 AngioDynamics Inc Earnings Release - Before Market Open |
| 06:12AM | AngioDynamics tops 3Q profit forecasts Associated Press |
| 06:00AM | AngioDynamics Reports Fiscal 2017 Third Quarter Results GlobeNewswire |
| Mar-29-17 10:45AM | Here's Why You Should Steer Clear of Mednax (MD) for Now |
| 10:45AM | Here's Why You Should Steer Clear of Mednax (MD) for Now Investopedia |
| Mar-27-17 06:55AM | AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City GlobeNewswire |
| Mar-20-17 06:00AM | AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results GlobeNewswire |
| Mar-15-17 10:12AM | AngioDynamics Microwave Tissue Ablation System Now CE Marked |
| Mar-14-17 06:00AM | AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System GlobeNewswire |
| Mar-13-17 09:02AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 13, 2017 |
| Mar-08-17 09:26AM | AngioDynamics to Present at the Barclays Global Healthcare Conference GlobeNewswire |
| Jan-20-17 08:32AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : January 20, 2017 |
| Jan-19-17 12:13PM | ETFs with exposure to AngioDynamics, Inc. : January 19, 2017 |
| Jan-17-17 08:14AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017 |
| Jan-12-17 01:04PM | ANGIODYNAMICS INC Financials |
| Jan-11-17 08:15AM | Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire |
| Jan-10-17 11:18AM | ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| Jan-09-17 09:51AM | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire |
| 08:03AM | AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View |
| Jan-06-17 02:46PM | Edited Transcript of ANGO earnings conference call or presentation 6-Jan-17 1:00pm GMT |
| 12:01PM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit |
| 07:07AM | Q2 2017 AngioDynamics Inc Earnings Release - Before Market Open |
| 06:08AM | AngioDynamics beats 2Q profit forecasts |
| 06:00AM | AngioDynamics Reports Fiscal 2017 Second Quarter Results GlobeNewswire |
| Jan-03-17 06:00AM | AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire |
| Dec-20-16 06:00AM | AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results GlobeNewswire |
| Dec-16-16 12:13AM | How Nantkwest Inc (NK) Stacks Up Versus Peers at Insider Monkey |
| Dec-09-16 11:09AM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : December 9, 2016 |
| 08:28AM | Is NeoGenomics, Inc. (NEO) A Good Stock To Buy? at Insider Monkey |
| Dec-08-16 01:14PM | Should You Follow the Smart Money Surge into AngioDynamics, Inc. (ANGO)? at Insider Monkey |
| 07:20AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : December 8, 2016 |
| Nov-29-16 03:30PM | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors Accesswire |
| Nov-28-16 11:31AM | ETFs with exposure to AngioDynamics, Inc. : November 28, 2016 |
| 09:30AM | Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks |
| 06:00AM | AngioDynamics to Participate in Upcoming Investor Conferences GlobeNewswire |
| Nov-25-16 07:05AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 25, 2016 |
| Nov-18-16 04:09PM | ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement |
| Nov-16-16 09:58AM | AngioDynamics (ANGO) Announces 2.5M Secondary Offering |
| Nov-15-16 01:09PM | ETFs with exposure to AngioDynamics, Inc. : November 15, 2016 |
| Nov-14-16 07:53PM | AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire |
| 04:09PM | AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders GlobeNewswire |
| 11:12AM | Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capitals Investment Moves? at Insider Monkey |
| 07:58AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 14, 2016 |
| Nov-10-16 04:12PM | ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitiv |
| 09:30AM | The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding |
| Nov-09-16 06:01AM | AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program GlobeNewswire |
| 06:00AM | AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc. GlobeNewswire |
| Nov-07-16 06:00AM | AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum GlobeNewswire |
| Nov-03-16 10:14AM | Becton, Dickinson (BDX) Beats on Q4 Earnings & Revenues |
|
|
|
|
| AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Gould Kevin J | Director | Sep 12 | Option Exercise | 14.03 | 39,000 | 547,170 | 65,064 | Sep 14 03:24 PM | | JOHNSON WESLEY | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 60,974 | Aug 08 05:48 PM | | Meteny Dennis S | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 83,127 | Aug 08 05:44 PM | | GOLD JEFFREY | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 66,037 | Jul 28 03:47 PM | | REED JAN STERN | Director | Jul 24 | Buy | 16.00 | 316 | 5,056 | 316 | Jul 25 02:33 PM | | DONNELLY HOWARD W | Director | Jul 21 | Buy | 15.72 | 5,000 | 78,600 | 47,600 | Jul 21 09:46 PM | | Clemmer James C | President and CEO | Jul 21 | Buy | 15.79 | 5,000 | 78,950 | 91,683 | Jul 21 06:43 PM | | Clemmer James C | President and CEO | Jul 20 | Buy | 15.64 | 20,000 | 312,800 | 86,683 | Jul 21 06:43 PM | | DONNELLY HOWARD W | Director | Jun 19 | Option Exercise | 15.75 | 14,000 | 220,500 | 56,144 | Jun 21 09:42 PM | | Burgstahler David F | Director | Apr 12 | Sale | 16.00 | 2,350,000 | 37,600,000 | 381,406 | Apr 14 04:48 PM | | Avista Capital Partners GP, LL | 10% Owner | Apr 12 | Sale | 16.00 | 2,350,000 | 37,600,000 | 381,406 | Apr 14 04:40 PM | | LaPorte Steve | Director | Jan 13 | Option Exercise | 15.75 | 14,000 | 220,500 | 48,201 | Jan 17 02:34 PM | | Avista Capital Partners GP, LL | 10% Owner | Nov 18 | Sale | 15.68 | 2,091,294 | 32,791,490 | 1,014,058 | Nov 22 04:20 PM | | Burgstahler David F | Director | Nov 18 | Sale | 15.68 | 2,091,294 | 32,791,490 | 1,014,058 | Nov 22 04:21 PM |
|
|
|
|
|
|
